May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 21, 2025

Medical Oddities: Fingernail Selfies Spot Anemia

Tea, tech, TikTok & toxins: surprising health twists hiding in phones, roads, and skin care.

Conexiant

May 16, 2025

Upadacitinib Maintains UC Remission Through 96 Weeks

A 3-year study found that most patients with moderate to severe ulcerative colitis who responded to initial upadacitinib treatment stayed in remission through 96 weeks, with manageable side effects and consistent results across dosage groups.

Conexiant

May 08, 2025

Naltrexone Forms Show Similar AUD Results

A randomized trial of 248 hospitalized patients with alcohol use disorder found no significant difference in drinking reduction between oral and injectable naltrexone.

Conexiant

May 08, 2025

High Poultry Intake May Be Linked to GI Cancer Mortality

Men who ate over 300 grams of poultry per week had more than double the risk of dying from gastrointestinal cancers, a large Italian study found.

Conexiant

May 06, 2025

Cannabis Use Disorder Tied to Mortality

A new study found colon cancer patients with cannabis use disorder were more than 10 times more likely to die within five years, even after adjusting for age and disease severity.

Conexiant

May 06, 2025

Biopsy Technique Improves Pancreatic Cyst Diagnosis Accuracy

A new study found that using endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) helped accurately diagnose pancreatic cysts in 60% of cases and significantly improved treatment decisions, especially when at least two needle passes were made.

Conexiant

May 06, 2025

Liver Stiffness Drop Tied to Inflammation, Not Fibrosis 

In a 72-week study of hepatitis B patients, researchers found liver stiffness declines were driven by improved inflammation, not actual fibrosis regression.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant